Interventions to Improve Adherence

Slides:



Advertisements
Similar presentations
Organization of Diabetes Care Chapter 6 Maureen Clement, Betty Harvey, Doreen M Rabi, Robert S Roscoe, Diana Sherifali Canadian Diabetes Association 2013.
Advertisements

Standard 3 Plan and Manage Care NCQA Recognition for Patient-Centered Medical Home 2011 Standards © Qualidigm.
Disease State Management The Pharmacist’s Role
Minor Consent Laws Kim Belasco – (619) Rachel Miller – (619)
10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Use of a Universal Medication List to Enhance Continuity of Care in Tennessee.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
IMPACTS OF PHARMACIST’S ROLES ON REDUCING READMISSION RATE AND PROMOTING PATIENT SAFETY IN PEDIATRIC CARDIAC PATIENTS Manita Suriyarangsee Monwarat Laohajeeraphan.
Innovations: Using a Clinical Pharmacist as a Vehicle for Successful P4P Outcomes Lisa Meland, B.S., PharmD. Helen Pervanas, R.Ph. WellPoint-WellPoint.
Integrating Evidence-Based Practice Into QI to Improve Patient Outcomes in HIV: Viral Load Suppression Victoria Lieb, ACRN, MPH; Carla Rossi, MD; Jaime.
Healthy People 2010 Focus Area 17: Medical Product Safety Progress Review October 19, 2007.
Mental Health Services for Our Campus: University Health Service Lori-Ann Lach, MD, CCFP Medical Director, University Health Service Student Support.
Your Medicine: Play it Safe. Your Health Care Team Doctors, nurse practitioners, and other medical professionals Nurses Pharmacists Use the link below.
March 2015 is. PHARMACISTS: TRUSTED CARE WHEN AND WHERE YOU NEED IT.
Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong.
Patient Centered Medical Home What it means for Duffy Health Center Board Presentation September 10 th 2012.
EHRS as a Tool to Improve BP Control 1.Brief history of OQIUN, CCI. Began 1999 using data cards. Started working with multiple practice sites using different.
INFLUENCE OF MEANINGFUL USE AMONG HEALTHCARE PROVIDERS Neely Duffey, Olivia Mire, Mallory Murphy, and Dana Sizemore.
Impact Health NDAC Meeting Stewart Levy R.Ph. January 14, 2005.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
LDL Program Medical Management Philip E. Johnston, Pharm.D.
1 Experience HealthND Medicaid Health Management Program.
The Center for Health Systems Transformation
Provider Tips and Toolsets Rural Quality Program Conference Office of Rural Health Policy Health Resources Services Administration September 2, 2009 Kathy.
Medication Therapy Management Programs in Community Pharmacy Community Pharmacy October 17, 2006 Kurt A. Proctor, Ph.D., RPh Chief Operating Officer Community.
Copyright © 2013, 2009, 2005 by Mosby, an imprint of Elsevier Inc. Chapter 19 Implementing Nursing Care.
[START WITH A PATIENT STORY – something compelling that demonstrates the value of diabetes education.] This patient’s story illustrates why I’m passionate.
Hepatitis C Support Groups Therapeutic BenefitsAdvocacy Benefits Patient education on disease state and treatment options Peer support Promote lifestyle.
Reducing Preventable Emergency Room Visits 1. An Opportunity Redirecting care to the most appropriate setting protects patient safety and ensures payment.
Adherence & the Role of Consumers & Carers in Medication Management Sue Henderson.
The Maryland P 3 (Patients Pharmacists Partnerships) Program TM A cost effective solution to patient-centered health education, medication adherence, and.
Readmissions Driver Diagram OHA HEN 2.0. Readmissions AIMPrimary Drivers Secondary DriversChange Ideas Reduce Readmissions Identify patients at high-risk.
YOUR PHARMACY / JOB- TITLE YOUR NAME Respiratory MUR.
An Inter-Professional Collaboration between a Family Medicine Center and a School of Nursing Maritza De La Rosa, MD New Jersey Family Practice Center Rutgers,
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Department of Public Health Presentation to the Health Cabinet June 14, 2016.
Cost-Effectiveness of Treatment Strategies for Comorbid Diabetes and Dyslipidemia Part 2.
Clinical Quality Improvement: Achieving BP Control
Clinical Project Meeting
Wireless Access SSID: cwag2017
History of the development of the pharmaceutical care
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Cheryl Schraeder, RN, PhD, FAAN Health Systems Research Center
Office of Health Systems Collaboration
Dedicated to Addressing Diabetes
February 15, 2011 Complex Care of Aging Families –Cindy Grindstaff R.N. The University of Akron Medina campus, RN to BSN program “Education and medication.
Promoting Medication Adherence: The Nursing Role
Clinical Pharmacy II.
HEDIS ® Measures & Tips: Behavioral Health
“Next Generation of Connected Health”
National Cholesterol Education Program
Demonstrate and Measure the Impact of the Application of the Principles of Medical Informatics in Low-Resource Settings Gerry Douglas, PhD Assistant Professor.
Centricity Physician Office
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Find and Treat All Missing Persons with TB
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
بررسی موانع خدمات مراقبت پرستاری در منزل در ایران
Improving Outcomes by Helping People Take Control
Provider and Member Education in Managed Care Pharmacy
Presented by: Steve Smith, MBA, FACMPE, CHFP, Managing Consultant
Simplify My Meds Patient’s prescriptions…simplified!
Home visiting evaluation
Pharmacy practice and the healthcare system Ola Ali Nassr
Goals & Guidelines A summary of international guidelines for CHD
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
The Heart Truth Delaware Background
User Personas Templates
Presentation transcript:

Interventions to Improve Adherence Focus on the patient Simplify medication regimens Provide explicit patient instruction and use good counseling techniques to teach the patient how to follow the prescribed treatment Encourage the use of prompts to help patients remember treatment regimens Use systems to reinforce adherence and maintain contact with the patient FUTURE RESEARCH

Interventions to Improve Adherence Focus on the patient Encourage the support of family and friends Reinforce and reward adherence Increase visits for patients unable to achieve treatment goal Increase the convenience and access to care Involve patients in their care through self-monitoring FUTURE RESEARCH

Interventions to Improve Adherence Focus on the Physician and Medical Office Teach physicians to implement lipid treatment guidelines Use reminders to prompt physicians to attend to lipid management Identify a patient advocate in the office to help deliver or prompt care Use patients to prompt preventative care Develop a standardized treatment plan to structure care Use feedback from past performance to foster change in future care Remind patients of appointments and follow up missed appointments FUTURE RESEARCH

Interventions to Improve Adherence Focus on the Health Delivery System Provide lipid management through a lipid clinic Utilize case management by nurses Deploy telemedicine Utilize the collaborative care of pharmacists Execute critical care pathways in hospitals FUTURE RESEARCH

Percent of Adults Who Need Lifestyle and Drug Treatment TLC Drug CHD and CHD Risk Equivalents 12.1 10.5 10-year risk >20% 2+ Risk Factors 5.5 4.2 10-year risk 10-20% 2+ Risk Factors 7.4 1.4 10-year risk <10% 0-1 Risk Factor 7.9 2.4 Total 33% 18.4% FUTURE RESEARCH

Percent of Adults (Millions) Who Need Lifestyle and Drug Treatment Therapeutic Lifestyle Changes (TLC) Drug CHD and CHD Risk Equivalents 24.1 20.7 10-year risk >20% 2+ Risk Factors 10.9 8.3 10-year risk 10–20% 2+ Risk Factors 14.6 2.8 10-year risk <10% 0–1 Risk Factor 15.6 4.7 Total 65.3M 36.5M FUTURE RESEARCH

NCEP Resources to Foster ATP III Implementation Professional Executive Summary ATP III At-A-Glance: Quick Desk Reference Web-based and electronic tools: Palm OS interactive tool--for use at point of care 10-year risk calculator PowerPoint slide set--for teaching FUTURE RESEARCH

NCEP Resources to Foster ATP III Implementation Patient “Live Healthier, Live Longer” Web site “High Blood Cholesterol: What you need to know”--patient brochure 10-year risk calculator FUTURE RESEARCH